Novartis AG launched a portfolio of 15 medicines to treat chronic diseases in low- and low-middle-income countries, the drugmaker said in a statement on Thursday.   The Basel-based company said ‘Novartis Access’ will be launched first in Kenya, Ethiopia and Vietnam, with expansion to eventually include 30 countries. Novartis said the portfolio addresses cardiovascular diseases, […]

ANI Pharmaceuticals to Acquire Two NDAs from Merck for $75 Million – Transaction Highlights:– Corticotropin-zinc hydroxide, 40 units/mL, NDA #009854– Assets will be acquired by foreign subsidiary to achieve more favorable tax treatment for ANI– Acquisition significantly advances ANI’s core strategy of re-commercializing previously approved products– Conference call to discuss transaction scheduled today at 10:00am […]

INGELHEIM and HEIDELBERG, Germany, September 21, 2015 /PRNewswire/ — Aims to identify of novel epigenetic drivers to find new approaches for treating COPD  Crowdsourcing used to find unconventional solutions and identify the best talent from around the world  New research team will be established at the BioMed X Innovation Center in Heidelberg, Germany and sponsored […]

GlaxoSmithKline’s inhaled medicine Breo failed to prolong life in patients with chronic respiratory disease in a high-stakes clinical trial of 16,500 people, torpedoing hopes of a sales boost for the drug. Shares in Britain’s biggest drugmaker fell 1.5 percent on Wednesday, lagging a strong London market, in reaction to the news announced by the company […]